George Sellers
Stock Analyst at Stephens & Co.
(1.30)
# 3,238
Out of 4,814 analysts
46
Total ratings
25%
Success rate
-9.84%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $31.58 | +115.33% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $129.55 | +123.85% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $41.19 | +40.83% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $88.24 | +101.72% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $13.98 | +71.74% | 6 | May 29, 2024 | |
| FNA Paragon 28 | Reiterates: Overweight | $18 | $12.99 | +38.57% | 3 | Apr 5, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $31.89 | +125.78% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $0.99 | +406.33% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $6.46 | +287.00% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $16.91 | +237.08% | 6 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $71 | $90.07 | -21.17% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $31.58
Upside: +115.33%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $129.55
Upside: +123.85%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $41.19
Upside: +40.83%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $88.24
Upside: +101.72%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $13.98
Upside: +71.74%
Paragon 28
Apr 5, 2024
Reiterates: Overweight
Price Target: $18
Current: $12.99
Upside: +38.57%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $31.89
Upside: +125.78%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $0.99
Upside: +406.33%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $6.46
Upside: +287.00%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $16.91
Upside: +237.08%
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $90.07
Upside: -21.17%